Vanguard Group’s LIBERATOR MED HLDGS INC (NY) LBMH Stock Holding History

Vanguard Group’s Portfolio LBMH Stock Details LBMH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-833,987	Closed	-$2.79M	–	4203
2015 Q4	$2.79M	Buy	833,987 +32,585	+4%	+$94.7K	﹤0.01%	3266
2015 Q3	$1.88M	Buy	801,402 +41,669	+5%	+$100K	﹤0.01%	3406
2015 Q2	$1.72M	Sell	759,733 -33,098	-4%	-$95.9K	﹤0.01%	3472
2015 Q1	$2.77M	Buy	792,831 +35,279	+5%	+$120K	﹤0.01%	3274
2014 Q4	$2.2M	Buy	757,552 +5,294	+0.7%	+$14.9K	﹤0.01%	3254
2014 Q3	$2.35M	Buy	752,258 +27,951	+4%	+$88.3K	﹤0.01%	3198
2014 Q2	$2.72M	Buy	724,307 +65,936	+10%	+$256K	﹤0.01%	3119
2014 Q1	$2.59M	Buy	+658,371	New	+$2.89M	﹤0.01%	3111

Vanguard Group's LBMH Position: Q1 2016 in Review

Vanguard Group sold out of LIBERATOR MED HLDGS INC (NY) (LBMH) in Q1 2016, closing a stake of 833,987 shares — an estimated $2.79M sold.

Vanguard Group first reported a position in LBMH in Q1 2014 and held it in 8 quarters. The position peaked at $2.79M in Q4 2015. 0 funds tracked by Wall St. Rank hold LBMH as of Q1 2016.

Vanguard Group reported no remaining LIBERATOR MED HLDGS INC (NY) position as of Q1 2016 after selling out during the quarter.
Vanguard Group sold 833,987 LIBERATOR MED HLDGS INC (NY) shares in Q1 2016, an estimated $2.79M.
Vanguard Group first reported a position in LIBERATOR MED HLDGS INC (NY) in Q1 2014 and held it in 8 quarters.
Vanguard Group's LIBERATOR MED HLDGS INC (NY) position peaked at $2.79M in Q4 2015.
0 funds tracked by Wall St. Rank held LIBERATOR MED HLDGS INC (NY) as of Q1 2016.

Based on Vanguard Group's 13F filing for Q1 2016, filed 13 May 2016.